Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.
Enrofloxacin: Mechanism of Action and Pharmacokinetics
Enrofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, leading to variable bacteriostatic effects and diverse pharmacokinetics across species.
Nov 29,2024 APIFurazolidone: History, Mechanism of Action and Adverse Effects
Furazolidone is a nitrofuran antimicrobial that disrupts bacterial metabolism, initially used for gastrointestinal infections, with common side effects like nausea and dizziness.
Nov 29,2024 APIUnderstanding Ferric Chloride Hexahydrate: Comprehensive Insights
The molecular formula of iron chloride hexahydrate is FeCl3.6H2O. The compound is also called Ferric Chloride Hexahydrate.
Nov 29,2024 APISodium Dihydrogenphosphate: An Essential Chemical in Various Applications
Sodium dihydrogenphosphate could be Used to prepare phosphorylated polysaccharide.
Nov 29,2024 API(Diacetoxyiodo)benzene: Applications in Organic Synthesis and Safety Considerations
(Diacetoxyiodo)benzene is a versatile reagent in organic synthesis. (Diacetoxyiodo)benzene efficiently oxidizes C-H bonds in benzylic acetals without costly metal catalysts, making it environmentally
Nov 28,2024 APIBilirubin: A Key Compound in Biochemical and Clinical Chemistry
Bilirubin is a well-known biological compound with significant implications in both biochemical and medical fields.
Nov 28,2024 APILincomycin Hydrochloride: Pharmacodynamics and Adverse Reactions
Lincomycin hydrochloride, a lincosamide antibiotic, treats Gram-positive and anaerobic bacteria but may cause severe reactions, including Clostridium difficile-associated diarrhea.
Nov 28,2024 APIChloramphenicol: Chemistry, Mechanism of Action and Pharmacokinetics
Chloramphenicol is a broad-spectrum antibiotic that can be taken orally or topically with minimal harmful effects. It is an Amphenicol-class Antibacterial.
Nov 27,2024 APILetermovir: Pharmacodynamics, Pharmacokinetics and Adverse Effects
Letermovir effectively inhibits cytomegalovirus, demonstrating high bioavailability, manageable pharmacokinetics, and tolerable adverse effects, with minimal risk of cross-resistance.
Nov 27,2024 APITelmisartan: The 'patron saint' of Hypertension Management
Among angiotensin II receptor blockers (ARBs), telmisartan was reported to be preferred by almost 73% of physicians in India as a first-line agent for managing essential hypertension.
Nov 27,2024 API












